Jove
Visualize
お問い合わせ

関連する概念動画

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Decoding the complex nexus: the mechanistic interplay of hyperhomocysteinemia in brain aging and neurological disorders.

Biogerontology·2026
Same author

Targeting excitatory/inhibitory neurotransmission by wogonin: integrated <i>In Silico</i> and <i>In Vivo</i> evidence in Parkinson's disease model.

Neurodegenerative disease management·2026
Same author

Pterostilbene Orchestrates Synaptic Remodeling and Mitochondrial Functional Reconstitution to Attenuate Ischemic Vascular Dementia.

Neuromolecular medicine·2026
Same author

Wogonin-mediated modulation of cellular signaling pathways: Mechanistic insights into neuroprotection.

Molecular biology reports·2026
Same author

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Intranasal administration of thermoresponsive pterostilbene loaded nanoemulgel confers neuroprotection in a rat model of ischemic stroke.

Nanomedicine (London, England)·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

薬物開発

Bhaskar Jyoti Dutta1

  • 1NIPER Hajipur, Hajipur, Bihar, India.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
まとめ

プテロスチルベン(PTE)は、高ホモシステイン(Hcy)レベルによって引き起こされる認知機能低下を逆転させます。この天然化合物は、記憶力、ミトコンドリア機能、神経新生を強化し、Hcy関連神経疾患の治療の可能性を提供します。

科学分野:

  • 神経科学
  • 生化学
  • 薬理学

背景:

  • ホモシステイン(Hcy)レベルの上昇、または高ホモシステイン血症(HHcy)は、神経疾患および認知障害に関連しています。
  • HHcyはメチル化とレドックスバランスを破壊し、カルシウム流入に影響を与え、アミロイド/タウ蓄積を促進します。
  • プテロスチルベン(PTE)は、抗酸化作用および抗炎症作用を持つ化合物であり、神経障害に対する有望性を示しています。

研究 の 目的:

  • 高ホモシステイン(HHcy)誘発性認知障害(HHcy-Cog)のラットモデルにおけるプテロスチルベン(PTE)の治療的可能性を調査すること。
  • HHcy-CogラットにおけるPTEの記憶、ミトコンドリア生合成、シナプス可塑性、および神経新生に対する効果を評価すること。

主な方法:

  • L-メチオニン投与によりHHcy-Cogのラットモデルを確立しました。
  • 動物には、L-メチオニン投与によりHHcy-Cogのラットモデルを確立しました。
  • 行動テスト(モリス水迷路、新規物体認識)を用いて認知機能を評価し、その後分子分析(組織病理学、IHC、ウェスタンブロット)を行いました。

主要な成果:

  • PTE治療は、HHcy-Cogラットにおける空間記憶および認識記憶を著しく改善しました。
  • PTEは、SIRT1/PGC-1α/TFAM経路を介してミトコンドリア生合成を強化し、シナプス可塑性を改善しました(シナプトフィジンおよびPSD-95の増加)。
キーワード:
プテロスチルベン高ホモシステイン認知障害神経新生ミトコンドリア生合成

さらに関連する動画

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

関連する実験動画

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451
  • PTEは、海馬におけるダブルドコーチン発現の増加によって示されるように、成体神経新生を支持しました。
  • 結論:

    • プテロスチルベン(PTE)は、高ホモシステイン誘発性の認知障害を効果的に軽減します。
    • PTEの治療効果は、記憶力、ミトコンドリア機能、シナプス可塑性、および成体神経新生の改善によって媒介されます。
    • PTEは、HHcyに関連する認知機能低下の治療薬としての可能性を示しています。